Form 4 for RMD ResMed|
Accepted 2024-08-06 00:00:00 ET · period of report 2024-08-05 · accession 0001127602-24-021754 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-06 | 2024-08-05 | RMD | Leong Justin | Pres, Asia Latin America | S - Sale | $217.07 | -48.0K | 18.7K | -72% | -$10.42M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2024-08-05 | S | D | 48,000 | $217.07 | 18,741 | D | — | — |